13.94
Schlusskurs vom Vortag:
$13.32
Offen:
$13.44
24-Stunden-Volumen:
1.21M
Relative Volume:
1.72
Marktkapitalisierung:
$814.69M
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$55.30M
KGV:
14.67
EPS:
0.95
Netto-Cashflow:
$-30.30M
1W Leistung:
+41.24%
1M Leistung:
+33.14%
6M Leistung:
-13.68%
1J Leistung:
-5.94%
Embecta Corp Stock (EMBC) Company Profile
Firmenname
Embecta Corp
Sektor
Telefon
(862) 401-0000
Adresse
1209 ORANGE STREET, WILMINGTON
Vergleichen Sie EMBC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
EMBC
Embecta Corp
|
13.94 | 779.02M | 1.12B | 55.30M | -30.30M | 0.95 |
![]()
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.43B | 2.26 |
![]()
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-10 | Eingeleitet | Mizuho | Neutral |
2024-12-02 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
2024-11-27 | Hochstufung | BTIG Research | Neutral → Buy |
2023-10-20 | Eingeleitet | Wolfe Research | Peer Perform |
2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
2022-09-08 | Eingeleitet | BTIG Research | Neutral |
2022-08-01 | Eingeleitet | Morgan Stanley | Equal-Weight |
2022-06-21 | Eingeleitet | BofA Securities | Underperform |
Alle ansehen
Embecta Corp Aktie (EMBC) Neueste Nachrichten
Embecta Corp. Reports Record Revenue and Debt Reduction - TipRanks
Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here's What You Should Know - Yahoo Finance
Embecta Corp. (NASDAQ:EMBC) Q3 2025 Earnings Call Transcript - Insider Monkey
Embecta To Go Ex-Dividend On August 29th, 2025 With 0.15 USD Dividend Per Share - 富途牛牛
Intraday Charts Show Spike in Embecta Corp. ActivitySecure Return Focused Investment Plan Released - beatles.ru
Market Cool On Embecta Corp.'s (NASDAQ:EMBC) Earnings - 富途牛牛
Embecta Corp. shares rise 1.06% intraday due to positive outlook in the insulin delivery device market. - AInvest
Mizuho raises Embecta stock price target to $14 on strong Q3 results - Investing.com Nigeria
Mizuho raises Embecta stock price target to $14 on strong Q3 results By Investing.com - Investing.com South Africa
Bloomberg Finance Expert Creates Essential Title for News Passage - AInvest
What makes Embecta Corp. stock price move sharplySmart Exit Timing Suggestions - mustnews.co.kr
Embecta Corp's Q3 2025 Outperformance: A Strategic Re-rating Opportunity Amid Margin Stability and Debt Reduction - AInvest
Embecta's 2025 Revenue Outlook: Navigating Regional Challenges and Valuation Opportunities - AInvest
This Embecta Insider Increased Their Holding By 20% Last Year - simplywall.st
Embecta 2025 Q3 Earnings Strong Performance as Net Income Surges 209.5% - AInvest
Embecta outlines revenue range of $1.078B-$1.085B for 2025 amid U.S. strength and China headwinds - MSN
Embecta Corporation Reports Strong Q3 2025 Results - TipRanks
What are the risks of holding Embecta Corp.Weekly Alpha Generating Watchlist - thegnnews.com
Healthcare Stocks Move in Friday's Pre-Market Session: OptimizeRx, Embecta, and More - AInvest
Embecta Beat Estimates And Raised Its Outlook For The Year - Finimize
Embecta (EMBC.O) Surges 16.55% — But No News. What’s Driving This Move? - AInvest
Embecta Shares Rise on 2Q Profit, Revenue Beat - 富途牛牛
Embecta stock gets a boost on Q3 beats, raised guidance - Drug Delivery Business
Embecta Q3 2025 Earnings Call Transcript - MarketBeat
Embecta Corp.'s Q3 2025 Earnings Call: Navigating Key Contradictions in Tariffs, Demand, and Financial Strategy - AInvest
Embecta projects 2025 revenue range of $1.078B-$1.085B, citing US strength and Chinese challenges. - AInvest
Embecta Corp. SEC 10-Q Report - TradingView
Transcript : Embecta Corp., Q3 2025 Earnings Call, Aug 08, 2025 - MarketScreener
Earnings call transcript: Embecta Q3 2025 beats expectations, stock surges By Investing.com - Investing.com South Africa
Earnings call transcript: Embecta Q3 2025 beats expectations, stock surges - Investing.com
Embecta Q3 FY 2025 slides: Revenue jumps 8.4%, guidance raised as stock surges - Investing.com Nigeria
Embecta Corp. Shares Soar 17.76% on Strong Q3 Earnings - AInvest
Embecta Boosts FY25 Adj. EPS Outlook; Stock Soars 18%Update - Nasdaq
Embecta Corp. Q3 Profit Increases, Beats Estimates - Nasdaq
Embecta Shares Rise Over 2% After Third-Quarter Results Beat Estimates - MSN
Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results - TradingView
Embecta Corp. Declares Quarterly Cash Dividend, Payable on September 15, 2025 - MarketScreener
Embecta earnings beat by $0.35, revenue topped estimates - Investing.com
Medical supplies company Embecta beats Q3 estimates, raises FY forecast - MarketScreener
Embecta shares rise over 2% as third quarter results surpass expectations - Investing.com Nigeria
Embecta raises FY23 outlook, Q3 revenue up 10% YoY. - AInvest
Press Release: Embecta Announces Quarterly Cash Dividend - 富途牛牛
Embecta's Quarterly Dividend Announcement: A Strategic Indicator of Financial Health and Investor Confidence - AInvest
Embecta declares quarterly dividend of $0.15 per share By Investing.com - Investing.com Canada
Embecta declares quarterly dividend of $0.15 per share - Investing.com India
embecta Announces Quarterly Cash Dividend - The Manila Times
An Overview of Embecta's Earnings - 富途牛牛
The Ultra-Fine™ Pen Needle is now part of embecta - retailpharmacymagazine.com.au
Diabetes Care Market to See Booming Growth 2025-2032 | Medtronic, Abbott, Pumps It, Inc., Embecta Corp - openPR.com
Can Embecta Corp. Escape Recent Bear ChannelRisk Controlled Short Term Trade Plans Published - metal.it
What institutional investors are buying Embecta Corp. stockInvest confidently with real-time updates - Jammu Links News
Finanzdaten der Embecta Corp-Aktie (EMBC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):